Eugene Wang, DO
Physical Medicine & Rehabilitation · Petoskey, MINPI 1922063908
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.2% of the total across 329 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 19.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,187, 2.3 times the $956 reported in 2019. Among physical medicine & rehabilitation clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 329 payments — averaging $26.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nevro Corp.$2K
- AbbVie$2K
- Biotronik NRO, Inc.$823
- Globus Medical$682
- Amgen$637
- Medtronic$405
- plus $3K from 29 others
What the payments were for
- Travel & lodging$5166%
- Food & beverage$7,91491%
- Education$70%
- Entertainment$2383%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nevro Corp. | 50 | $1,680 |
| AbbVie(2 entities) | 110 | $1,676 |
| Biotronik NRO, Inc. | 4 | $823 |
| Globus Medical | 13 | $682 |
| Amgen(2 entities) | 28 | $637 |
| Medtronic(2 entities) | 11 | $405 |
| Collegium Pharmaceutical, Inc. | 21 | $265 |
| Boston Scientific | 7 | $258 |
| Bioness Inc | 1 | $238 |
| Si-bone, Inc. | 4 | $236 |
| Abbott | 5 | $203 |
| Merz Pharmaceuticals, LLC | 8 | $189 |
| Stryker | 3 | $181 |
| Vertos Medical, Inc. | 1 | $163 |
| Lilly USA, LLC | 10 | $151 |
| Biodelivery Sciences International, Inc. | 9 | $144 |
| Pfizer | 6 | $117 |
| Radius Health, Inc. | 6 | $83 |
| Vertex | 3 | $77 |
| Lundbeck LLC | 3 | $60 |
| Bioventus LLC | 3 | $60 |
| Novartis | 4 | $59 |
| Teva Pharmaceuticals USA, Inc. | 4 | $54 |
| Indivior Inc. | 3 | $51 |
| Upsher-smith Laboratories LLC | 2 | $26 |
| Biohaven Pharmaceuticals, Inc. | 1 | $25 |
| Braeburn Inc. | 1 | $20 |
| SPR Therapeutics, Inc | 1 | $19 |
| Pacira Therapeutics, Inc. | 1 | $19 |
| Fidia Pharma USA Inc. | 1 | $15 |
| Ferring Pharmaceuticals Inc. | 1 | $15 |
| Johnson & Johnson | 1 | $14 |
| Ipsen Biopharmaceuticals, Inc | 1 | $14 |
| Assertio Therapeutics, Inc. | 1 | $13 |
| Alkermes, Inc. | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Senza$540
- Omnia$410
- Senza Spinal Cord Stimulation System$346
- mild Device Kit$274
- AIMOVIG$248
- Stimrouter for pain$238
- Prospera$164
- INTELLIS ADAPTIVESTIM$150
- BIOTRONIK$142
- Mavyret$125
- BOTOX$121
- Axium$101
How this compares
$8,675 in reported general payments places this provider in the 95th percentile of 469 physical medicine & rehabilitation providers in Michigan.
See all physical medicine & rehabilitation providers in Michigan →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| QuliptaAtogepant | 12 | $12,328 |
| Aimovig AutoinjectorErenumab-Aooe | 12 | $8,438 |
| Fentanyl | 16 | $3,144 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 86 | $2,396 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 14 | $2,237 |
| Gabapentin | 98 | $1,736 |
| Pregabalin | 76 | $1,532 |
| Buprenorphine | 14 | $1,079 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 46 | $782 |
| Buprenorphine Hcl | 18 | $769 |
| Morphine Sulfate | 16 | $680 |
| Morphine Sulfate ErMorphine Sulfate | 22 | $598 |
| Oxycodone Hcl | 19 | $427 |
| Celecoxib | 19 | $161 |
| Tizanidine Hcl | 20 | $145 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieQulipta | $1,676 | $12,32812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 469 physical medicine & rehabilitation providers in Michigan.
Other physical medicine & rehabilitation in Petoskey
- Jason PetermanPetoskey$6K
- Adam AncelPetoskey$3K
- Edward DabrowskiRoseville$167K
- Erika ErlandsonAnn Arbor$54K
- Gianna Maria RodriguezAnn Arbor$41K
- Mathew SaffarianEast Lansing$24K
- Jason PeterTroy$20K
- David WiersemaSaginaw$17K
- Satyum ParikhWarren$11K
- Reginald KapteynMuskegon$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.